Navigation Links
Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension

lood vessels and other organs such as the kidney and the brain. Blood pressure is determined in two phases as the heart contracts and relaxes. Systolic blood pressure represents the force that blood exerts on the walls of arteries as the heart contracts to pump out blood. Diastolic blood pressure represents the force as the heart relaxes to allow the blood to flow into the heart.

Due to its wide prevalence and impact on cardiovascular health, hypertension is a major cause of disease and death in Europe and North America. More than one in three Europeans and North Americans over the age of 35 suffers from hypertension - but for the vast majority of patients who undergo hypertension treatment, the causes of high blood pressure are unknown. More than 40 % of patients undergoing treatment with current therapies do not reach targeted blood pressure levels, and so there is a considerable unmet medical need.
The latest potential therapeutic agents for hypertension are renin inhibitors. Renin is an enzyme produced in the kidneys in response to reduced renal perfusion. Through a cascade of biological events, renin acts to bring about sodium retention, an increase in blood pressure, and restoration of renal perfusion, which shuts off the signal for renin release. For hypertensive individuals, renin inhibitors are currently being investigated as a therapy that may provide benefits over current therapies to reduce blood pressure, decrease salt retention and may protect end organs such as the kidney, heart and brain.

About Speedel
Speedel is a public biopharmaceutical company that seeks to create value for patients, partners and investors by developing innovative therapies for cardiovascular and metabolic diseases. Speedel is a world leader in renin inhibition, a promising new approach with significant potential for treating cardiovascular diseases. Our lead compound SPP100 (Tekturna/Rasilez [i]), the first-in-class direct renin inhibitor,
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
2. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
3. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
4. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
5. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
6. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
7. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
8. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
9. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
10. Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia
11. Bentley Reports Positive Results with Nasulin Intranasal Insulin Spray at the American Diabetes Association Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Speedel Reports Successful SPP635 Phase IIa Trial Hypertension
(Date:9/3/2015)... , Sept. 3, 2015  Cipla, a global ... the everyday needs of all patients, today announced that ... agreements to acquire two US-based companies, InvaGen Pharmaceuticals Inc., ... certain closing conditions, is valued at $550 million and ... from these transactions is over $200 million for the ...
(Date:9/3/2015)... Report Details Ovarian Cancer ... Changes and Emerging Opportunities What,s the future for ... study forecasts those pharmaceutical revenues. There you find ... also explore trends, results, treatments, R&D, and opportunities, ... predictions to 2025 at overall world market, submarket, ...
(Date:9/3/2015)... , Sept. 3, 2015 ... devices market? Which areas are going to grow at ... potential revenues to 2025, assessing data, trends, opportunities and ... tables, charts, and graphs. Discover the most lucrative areas ... new study lets you assess forecasted sales at overall ...
Breaking Medicine Technology:Cipla to acquire 100% of generic businesses in US for $550M 2Cipla to acquire 100% of generic businesses in US for $550M 3Cipla to acquire 100% of generic businesses in US for $550M 4Cipla to acquire 100% of generic businesses in US for $550M 5Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 2Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 3Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 4Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 5Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 6Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 2Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 3Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 4
... YORK , July 6 Reportlinker.com announces that a new market research ... , ... , , ... , , The ...
... July 6 There are more than 374,000 smokers in the state of ... illness.(1) As of July 1 , they now have an added incentive to ... restaurants, bars and workplaces as a result of the Kansas Indoor Clean Air Act.(2) ... Research shows that policy changes, like the new ...
Cached Medicine Technology:Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 2Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 3Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 4Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 5Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 6Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 7Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 8Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 9Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 10Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 11Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 12Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 13Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 14Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 15Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 16Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 17Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 18Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 19Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 20Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 21Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 22Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 23Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 24Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 25Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 26Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 27Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 28Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 29Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 30Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 31Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 32Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 33Kansas Statewide Smoking Ban May Prompt Smokers to Quit 2Kansas Statewide Smoking Ban May Prompt Smokers to Quit 3Kansas Statewide Smoking Ban May Prompt Smokers to Quit 4
(Date:9/3/2015)... ... September 03, 2015 , ... The Linda Hall Library ... of a comet, the IceCube observatory at the South Pole, and the interior of ... Fall Lecture Series for the world's foremost independently funded research library devoted to science, ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... provider of comprehensive eating disorder treatment for adults and adolescents struggling with ... Calinoiu, MD has joined the medical treatment team. As a Staff Psychiatrist, ...
(Date:9/3/2015)... York, New York (PRWEB) , ... September 03, 2015 , ... ... of the Division of Trauma, Burns, Critical and Acute Care at NewYork-Presbyterian/Weill Cornell Medical ... College. , Dr. Winchell is a nationally renowned expert in care for the critically ...
(Date:9/3/2015)... ... , ... Global Vision , the world leader in the development of ... and artwork inspection solutions, ScanProof and ArtProof at Packaging Innovations 2015. ... booth #F33 , Be the first to get a sneak peek of Intelligent Proofreading. ...
(Date:9/3/2015)... ... 03, 2015 , ... Atlantic Information Services, Inc. (AIS) is ... Strategies for a Rapidly Changing Marketplace.” In this Sept. 16 program, pharmacy benefit ... how plan sponsors are adopting bold, innovative strategies to control soaring specialty pharmacy ...
Breaking Medicine News(10 mins):Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 2Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 3Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 4Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 5Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 2Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 3Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 2Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 3Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 4Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 5Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 2Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 3Health News:Speakers for Upcoming AIS Virtual Conference on Pharmacy Benefit Strategies Include Executives from CVS Health, Express Scripts 2
... BROOK, Ill. January 25, 2008 A recent ... that hospitalizations for disorders caused by gastroesophageal reflux disease or ... for patients who had milder forms of GERD (in addition ... 216 percent during the same time period. The numbers underscore ...
... AARP CEO Bill Novelli,made the following statement about next Monday,s ... & Perata) by the California State Senate,Committee on Health:, ... we strongly,urge the members of the State Senate Health Committee ... vote next Monday. ABX 1 1 represents a major step ...
... Role of Certifying Boards in Quality Measurement ... that PQRI,- Medicare,s new program for rewarding ... improved, the Senate Finance Committee has issued,recommendations ... Services (CMS) to,include alternatives for measuring and ...
... a speech,earlier this week, Wal-Mart Chief Executive Officer ... stages of offering pharmacy benefit manager,services. In response ... the National Community Pharmacists Association (NCPA) issued the,following ... be reformed. The current PBM business,model is one ...
... Tech associate professor of biological sciences, has an original theory ... $150,000 grant from Space Florida to test it. The grant ... Health Branch. , He is also the sole medical researcher ... Kennedy Space Center (KSC) and the research is being conducted ...
... of a drug to activate stem cells that differentiate into ... may be a potential treatment strategy for osteoporosis, according to ... The study led by researchers from Massachusetts General ... found that treatment with a medication used to treat bone ...
Cached Medicine News:Health News:ASGE encourages patients to see a physician if they experience symptoms suggestive of GERD 2Health News:ASGE encourages patients to see a physician if they experience symptoms suggestive of GERD 3Health News:ASGE encourages patients to see a physician if they experience symptoms suggestive of GERD 4Health News:Senate Finance Committee Recommends Ways That Medicare Can Enhance Current Physician Quality Reporting Initiative (PQRI) 2Health News:NCPA Statement on Wal-Mart's Entry Into the Pharmacy Benefit Market 2Health News:Controversial theory of Alzheimer's origin funded 2Health News:Turning on adult stem cells may help repair bone 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: